Stock CTKB CYTEK BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Cytek Biosciences, Inc.

Equities

CTKB

US23285D1090

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-17 pm EDT 		5-day change 1st Jan Change
6.1 USD -1.29% Intraday chart for Cytek Biosciences, Inc. -3.17% -33.11%
May. 13 Piper Sandler Adjusts Price Target on Cytek Biosciences to $8.50 From $10, Maintains Overweight Rating MT
May. 08 Earnings Flash (CTKB) CYTEK BIOSCIENCES Reports Q1 Revenue $44.9M, vs. Street Est of $43.6M MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Advanced Medical Equipment & Technology

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
CYTEK BIOSCIENCES, INC. Stock Cytek Biosciences, Inc.
 801M -
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
 227B
DANAHER CORPORATION Stock Danaher Corporation
 197B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
 141B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
 110B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
 64.15B
  1. Stock Market
  2. Equities
  3. CTKB Stock
  4. Charts Cytek Biosciences, Inc.
  5. Sector Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW